NACL Industries Ltd
NACL is an established player and they deal in both technicals and formulations and they cater to the Indian market and to the international market as well. They have over 50 products covering all major crops. They have a strong logistic presence and the products are sold in more than 55,000 counters. NACL has become one of the reliable contract manufacturers for major MNCs. NACL exports products to over 30 countries and has forayed into International Brand business by registering brands in South-East Asia and Africa and are in the process of expanding reach in these regions. [1] [2]
- Market Cap ₹ 1,642 Cr.
- Current Price ₹ 82.5
- High / Low ₹ 111 / 70.0
- Stock P/E 20.1
- Book Value ₹ 26.8
- Dividend Yield 0.67 %
- ROCE 15.4 %
- ROE 16.2 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 35.4% CAGR over last 5 years
Cons
- Stock is trading at 3.07 times its book value
- Company has a low return on equity of 12.3% over last 3 years.
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -5.98%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
643 | 601 | 636 | 746 | 692 | 735 | 847 | 865 | 1,015 | 1,191 | 1,640 | 1,995 | |
572 | 583 | 625 | 701 | 636 | 679 | 798 | 852 | 946 | 1,078 | 1,502 | 1,831 | |
Operating Profit | 71 | 18 | 11 | 44 | 56 | 56 | 49 | 14 | 69 | 113 | 138 | 165 |
OPM % | 11% | 3% | 2% | 6% | 8% | 8% | 6% | 2% | 7% | 10% | 8% | 8% |
4 | 18 | 16 | 26 | 18 | 41 | 20 | 27 | 8 | 15 | 13 | 9 | |
Interest | 33 | 31 | 28 | 35 | 37 | 38 | 33 | 34 | 29 | 28 | 27 | 38 |
Depreciation | 27 | 25 | 22 | 25 | 27 | 28 | 20 | 20 | 24 | 25 | 25 | 26 |
Profit before tax | 14 | -20 | -23 | 10 | 11 | 31 | 15 | -13 | 24 | 75 | 100 | 110 |
Tax % | 49% | 36% | 9% | 27% | 18% | -4% | 25% | 48% | 30% | 32% | 26% | |
Net Profit | 7 | -13 | -21 | 8 | 10 | 33 | 12 | -7 | 17 | 51 | 73 | 82 |
EPS in Rs | 0.40 | -0.70 | -1.32 | 0.54 | 0.62 | 2.09 | 0.74 | -0.42 | 0.87 | 2.60 | 3.70 | 4.12 |
Dividend Payout % | 31% | 0% | 0% | 19% | 16% | 6% | 17% | 0% | 12% | 15% | 15% |
Compounded Sales Growth | |
---|---|
10 Years: | 10% |
5 Years: | 17% |
3 Years: | 24% |
TTM: | 33% |
Compounded Profit Growth | |
---|---|
10 Years: | 26% |
5 Years: | 35% |
3 Years: | 132% |
TTM: | 16% |
Stock Price CAGR | |
---|---|
10 Years: | 38% |
5 Years: | 16% |
3 Years: | 60% |
1 Year: | 1% |
Return on Equity | |
---|---|
10 Years: | 6% |
5 Years: | 9% |
3 Years: | 12% |
Last Year: | 16% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 15 | 16 | 16 | 16 | 16 | 16 | 17 | 19 | 20 | 20 | 20 | |
Reserves | 192 | 180 | 159 | 162 | 170 | 213 | 223 | 247 | 338 | 397 | 469 | 511 |
220 | 177 | 219 | 228 | 232 | 213 | 237 | 210 | 268 | 202 | 530 | 664 | |
204 | 228 | 227 | 260 | 193 | 209 | 237 | 268 | 330 | 357 | 492 | 601 | |
Total Liabilities | 631 | 600 | 621 | 665 | 611 | 651 | 713 | 742 | 955 | 976 | 1,510 | 1,795 |
192 | 172 | 182 | 176 | 167 | 163 | 158 | 141 | 191 | 220 | 238 | 248 | |
CWIP | 16 | 11 | 18 | 12 | 6 | 7 | 5 | 21 | 42 | 36 | 116 | 188 |
Investments | 4 | 4 | 9 | 12 | 13 | 9 | 9 | 14 | 15 | 16 | 13 | 13 |
419 | 413 | 411 | 466 | 426 | 473 | 541 | 566 | 707 | 704 | 1,143 | 1,346 | |
Total Assets | 631 | 600 | 621 | 665 | 611 | 651 | 713 | 742 | 955 | 976 | 1,510 | 1,795 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|
36 | 76 | 31 | 40 | 46 | 58 | 24 | 36 | 103 | 83 | -124 | |
-24 | -5 | -47 | -18 | -12 | -6 | -14 | -27 | -97 | 14 | -163 | |
-10 | -74 | 11 | -27 | -33 | -58 | -11 | -9 | 70 | -113 | 290 | |
Net Cash Flow | 2 | -3 | -5 | -4 | 1 | -5 | -1 | 0 | 77 | -16 | 2 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 111 | 100 | 92 | 108 | 99 | 110 | 124 | 113 | 129 | 103 | 118 |
Inventory Days | 148 | 154 | 140 | 138 | 153 | 189 | 141 | 134 | 84 | 100 | 124 |
Days Payable | 123 | 113 | 97 | 121 | 89 | 127 | 127 | 125 | 137 | 120 | 117 |
Cash Conversion Cycle | 135 | 141 | 135 | 125 | 163 | 172 | 137 | 122 | 76 | 83 | 124 |
Working Capital Days | 108 | 97 | 93 | 90 | 119 | 126 | 124 | 125 | 90 | 89 | 125 |
ROCE % | 3% | 2% | 11% | 12% | 10% | 11% | 4% | 10% | 17% | 15% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 1d
- Closure of Trading Window 1d
- Intimation Of Grant Of Environment Clearance (EC) To M/ S.NACL Multichem Private Limited, A Wholly-Owned Subsidiary Of The Company 15 Mar
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 9 Mar
- A) Allotment Of Equity Shares Upon Exercise Of Vested Options Under Nagarjuna Agrichem Ltd.-Employee Stock Option Scheme-2015 (ESOS-2015 Scheme) And NACL Employee Stock Option Scheme-2020 (ESOS-2020 Scheme). B) Forfeiture And Grant Of Stock Options Under ESOS-2020 Scheme. 24 Feb
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Jan 2022TranscriptNotesPPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Mar 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
Products
Key technicals:
Myclobutanil: It is a triazole chemical used as a fungicide.
Propiconazole: It is a triazole fungicide. Profenofos: It is an organophosphate insecticide.
Pretilachlor: Herbicide, Tricyclazole: Fungicide. [1]
New products: The Company has successfully commercialized two new Technical / Active Ingredients namely Lambda Cyhalothrin and Bispyribac Sodium. They also introduced 7 formulated products. [2]